EORTC AISBL / IVZW Avenue Mounierlaan, 83/11 Brussel 1200 Bruxelles • Belgie Belgique +32 2 774 16 11
Intranet • Home

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background

20011

A randomized trial of BEAM + PBSCT versus single agent high-dose therapy followed by BEAM + PBSCT in patients with relapsed Hodgkin's disease (HD-R2 protocol).

Back to Protocol section